Molecular structure of Meclocycline sulfosalicylate salt, CAS Number: 73816-42-9
Meclocycline sulfosalicylate salt (CAS 73816-42-9)
CAS Number:
73816-42-9
Molecular Weight:
695.05
Molecular Formula:
C29H27ClN2O14S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Meclocycline sulfosalicylate salt is a compound that functions as an inhibitor of matrix metalloproteinases (MMPs). It acts by chelating the zinc ion at the active site of MMPs, thereby preventing the enzymatic degradation of extracellular matrix components such as collagen and proteoglycans. By interfering with MMP function, Meclocycline sulfosalicylate salt can be used to investigate the role of MMPs in processes such as tissue remodeling, wound healing, and tumor invasion. Its mechanism of action involves specifically targeting the catalytic site of MMPs, leading to the suppression of their proteolytic activity without affecting other cellular processes.
Meclocycline sulfosalicylate salt (CAS 73816-42-9) References
- An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds. | Boshuizen, RS., et al. 2004. Anal Biochem. 333: 372-80. PMID: 15450815
- Polyanion induced fibril growth enables the development of a reproducible assay in solution for the screening of fibril interfering compounds, and the investigation of the prion nucleation site. | Boshuizen, RS., et al. 2007. Amyloid. 14: 205-19. PMID: 17701468
- Determination of photoirradiated tetracyclines in water by high-performance liquid chromatography with chemiluminescence detection based reaction of rhodamine B with cerium (IV). | Santiago Valverde, R., et al. 2007. J Chromatogr A. 1167: 85-94. PMID: 17765910
- Inhibition of Listeria monocytogenes infection by neurological drugs. | Lieberman, LA. and Higgins, DE. 2010. Int J Antimicrob Agents. 35: 292-6. PMID: 20031379
- Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. | Villar-Piqué, A., et al. 2012. Microb Cell Fact. 11: 55. PMID: 22553999
- NDST1 Preferred Promoter Confirmation and Identification of Corresponding Transcriptional Inhibitors as Substrate Reduction Agents for Multiple Mucopolysaccharidosis Disorders. | Tkachyova, I., et al. 2016. PLoS One. 11: e0162145. PMID: 27657498
- Atomic-resolution structures from fragmented protein crystals with the cryoEM method MicroED. | de la Cruz, MJ., et al. 2017. Nat Methods. 14: 399-402. PMID: 28192420
- Optimization of a High-Throughput 384-Well Plate-Based Screening Platform with Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 15442 Biofilms. | Gilbert-Girard, S., et al. 2020. Int J Mol Sci. 21: PMID: 32344836
- Data supporting a pilot high-throughput screen of a drug library for identification of DYRK1A inhibitors and high-content imaging analysis of identified harmine analogs. | Tarpley, M., et al. 2021. Data Brief. 37: 107189. PMID: 34141844
- Solving matrix-effects exploiting the second order advantage in the resolution and determination of eight tetracycline antibiotics in effluent wastewater by modelling liquid chromatography data with multivariate curve resolution-alternating least squares and unfolded-partial least squares followed by residual bilinearization algorithms: I. Effect of signal pre-treatment | M.M. De Zan，M.D. Gil García. 1 February 2008,. Journal of Chromatography A. Volume 1179, Issue 2,: Pages 106-114.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Meclocycline sulfosalicylate salt, 500 mg | sc-235581 | 500 mg | $66.00 |